A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand

American Journal of Tropical Medicine and Hygiene

Volumn 64, Issue 5, 2001, Pages 247-256

  Lefèvre, Gilbert ^a   Looareesuwan, Sornchai ^b   Treeprasertsuk, Sombat ^b   Krudsood, Srivicha ^b   Silachamroon, Udomsak ^b   Gathmann, Insa ^c   Mull, Robert ^c   Bakshi, Rajesh ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b MAHIDOL UNIVERSITY   (Thailand)

^c WSJ 277029 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; MEFLOQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLEARANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALARIA; MALE; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; THAILAND;

EID: 0034946077     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.64.247     Document Type: Article

References (11)

1. Wernsdorfer WH, 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143-156.
2. Olliaro PL, Trigg PI, 1995. Status of antimalarial drugs under development. Bull World Health Organ 73: 565-571.
3. White NJ, 1992. Antimalarial drug resistance: the pace quickens: J Antimicrob Chemother 30: 571-585.
4. Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Suntharasamai P, Charoenlarp P, Arnold K, Kyle D, Canfield C, Webster K, 1992. Randomized trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339: 821-824.
5. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Pa Eh J, Chongsuphajaisiddhi T, White NJ, 1994. Treatment of multidrug resistant Plasmodium falciparum malaria with a 3 day artesunate-mefloquine combination. J Infect Dis 170: 971-977.
6. Price RN, Nosten F, Luxemburger C, Kham A, Brockman A, Chongsuphajaisiddhi T, White NJ, 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 523-527.
7. van Vugt M, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, Luxemburger C, White NJ, Nosten F, Looareesuwan S, 1999. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant falciparum malaria. Am J Trop Med Hyg 60: 936-942.
8. Looareesuwan S, Wilairatana P, Chalermarut K, Rattanapong Y, Canfield CJ, Hutchinson DBA, 1999. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 60: 526-532.
9. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DBA, 1999. Malarone™ (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Am J Trop Med Hyg 64: 533-541.
10. Lefèvre G, Thomsen MS, 1999. Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Invest 18: 467-480.
11. van Agtmael M, Cheng-Qi S, Qing JX, Mull R, van Boxtel CJ, 1999. Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria. Int J Antimicrob Agents 12: 151-158.